New FDA Approved Light Therapy for Macular Degeneration Raises Questions
Experts Debate Whether the Valeda Light Delivery System Was Approved Too Soon
Topline
A novel light therapy device for dry age-related macular degeneration (AMD) has been approved, but experts warn that critical questions about its efficacy and safety remain. While the LIGHTSITE III trial demonstrated modest improvements in visual acuity, concerns about small sample size, treatment burden, and long-term effects suggest the need fo…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.